Contributions to the optimal use of human blood. IV. Quantitative analysis of the immunoglobulin isolation.
D000906:Antibodies / Q000032:analysis; D000914:Antibodies, Viral / Q000032:analysis; D000918:Antibody Specificity; D000989:Antistreptolysin / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D005069:Evaluation Studies as Topic; D006386:Hemagglutination Tests; D006462:Hemolytic Plaque Technique; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A / Q000302:isolation & purification; D007074:Immunoglobulin G / Q000302:isolation & purification; D007075:Immunoglobulin M / Q000302:isolation & purification; D007136:Immunoglobulins / Q000032:analysis*; D008459:Measles virus / Q000276:immunology; D009500:Neutralization Tests; D011863:Radioimmunoassay; D012204:Rh-Hr Blood-Group System; D013743:Tetanus Antitoxin / Q000032:analysis; D014361:Trypsin Inhibitors / Q000032:analysis; D014616:Vaccinia virus / Q000276:immunology
D000906:Antibodies; D000914:Antibodies, Viral; D001798:Blood Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System; D013743:Tetanus Antitoxin; D014361:Trypsin Inhibitors; D000989:Antistreptolysin